from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0475/hbhA

LFCtreatmentdescriptionclass of inhibitor

1.519

Amikacinug/mL Amikacintranslation

1.079

Cap5-10ug/mL Capreomycintranslation

1.046

Rox10-50 ug/mL Roxithromycintranslation

0.853

SM2-5 ug/mL Streptomycintranslation

1.237

Tet5-10 ug/mL Tetracyclinetranslation

0.047

Rif0.2-5ug/mL Rifampicintranscription

0.545

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.073

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.451

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.022

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.620

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.723

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.656

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.443

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.739

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.638

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.392

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.501

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.078

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.111

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.127

KCN5-20 ug/mL Potassium cyaniderespiration

-0.049

NaN30.2-2 mM Sodium aziderespiration

0.486

Nigericin50 uM Nigericinrespiration

1.029

TRC10-150 ug/mL Triclosanrespiration

0.607

TRZ10-25 ug/mL Thioridazinerespiration

1.640

Valinomycin0.5-10 uM Valinomycinrespiration

-1.414

ZnSO42 mM ZnSO4respiration

1.310

menadione6-10 ug/mL Menadionerespiration

-0.216

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.941

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.090

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.423

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.719

NRP_1Non-replicating persistence stage 1dosRassociated

-0.223

Amp0.2mg/mL AmpicillincellWall

-0.819

Cephalexin20-100 ug/mL CephalexincellWall

-0.084

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.551

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.649

EMB10-20 ug/mL EthambutolcellWall

-1.368

Eta12-40 ug/mL EthionamidecellWall

-1.348

INH0.2-0.4 ug/mL IsoniazidcellWall

0.124

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.274

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.949

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.317

BZA0.12 mg/mL BenzamidearomaticAmides

0.117

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.088

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.847

H2O24 mM hydrogen peroxideDNAdamaging

-0.093

Levo10 ug/mL LevofloxacinDNAdamaging

-0.801

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.204

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.547

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.433

UVUV-irradiationDNAdamaging

0.851

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.511

Antimycin12.5-50 ug/mL Antimycin A?

0.172

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.053

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.257

PA8240.2-2 ug/mL PA-824?

-0.761

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.715

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.080

Verapamil50 uM Verapamil?

0.164

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.326

methoxatin10-20 ug/mL Methoxatin?